Karyopharm Therapeutics Inc.
KPTI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001503802
In the last 90 days, Karyopharm Therapeutics Inc. insiders filed 0 open-market purchases and 3 sales; 96 institutions reported holding it in 13F filings for Q2 2026, worth $206.8M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Karyopharm Therapeutics Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 138 | 120 | −18 |
| Shares | 81.5M | 77.2M | −4.32M (−5.3%) |
| Value | $145.0M | $102.8M | −$42.2M (−29.1%) |
New holders (16)
Institutions that held Karyopharm Therapeutics Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 568,298 | $762.0K | 0.07% |
| Bridgeway Capital Management, LLC | 289,500 | $387.9K | 0.01% |
| Woodline Partners LP | 134,112 | $179.7K | 0.00% |
| Wade G W & Inc | 45,140 | $60.0K | 0.00% |
| State of Wyoming | 40,741 | $54.6K | 0.01% |
| Squarepoint Ops LLC | 34,154 | $45.8K | 0.00% |
| Brevan Howard Capital Management LP | 22,824 | $30.6K | 0.01% |
| Simplex Trading, LLC | 21,506 | $28.0K | 0.00% |
| Nomura Holdings Inc | 19,433 | $26.0K | 0.00% |
| Prudential Financial Inc | 19,415 | $26.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 14,964 | $20.1K | 0.00% |
| Headlands Technologies LLC | 13,817 | $18.5K | 0.01% |
| Brinker Capital Investments, LLC | 13,039 | $17.5K | 0.00% |
| Orion Portfolio Solutions, LLC | 13,039 | $17.5K | 0.00% |
| Neuberger Berman Group LLC | 11,234 | $15.1K | 0.00% |
| Point72 Asset Management, L.P. | 272 | $364 | 0.00% |
Sold out (34)
Institutions that held Karyopharm Therapeutics Inc. at the end of Q2 2023 and filed for Q3 2023 without it.